FREAMINE III 3% W/ ELECTROLYTES
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
Approval overview FREAMINE III 3% W/ ELECTROLYTES is listed in Drugs@FDA under application 016822 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE Form and strength INJECTABLE;INJECTION - 3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML Sponsor B BRAUN Submission history Latest submission status date: 2014-03-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview FREAMINE III 3% W/ ELECTROLYTES is listed in Drugs@FDA under application 016822 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE Form and strength INJECTABLE;INJECTION - 3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML Sponsor B BRAUN Submission history Latest submission status date: 2014-03-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.